Compare Citius Pharmaceuticals Inc (CTXR) vs VanEck Video Gaming and eSports ETF (ESPO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs VanEck Video Gaming and eSports ETF — how do they compare? Citius Pharmaceuticals Inc trades at $0.53 (market cap $14.64M), while VanEck Video Gaming and eSports ETF trades at $91.42. The key difference: VanEck Video Gaming and eSports ETF is trading nearer its 52-week high, Citius Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| CTXR | ESPO | |
|---|---|---|
Market Cap | $14.64M | — |
Sector | Health | Sector/Thematic |
52-Week High | $1.82 | $122.30 |
52-Week Low | $0.53 | $85.25 |
Enterprise Value | $10.86M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CTXR trades at $0.54, down 7.33% in the last session, with a bearish technical signal from moving averages. The company reported a net loss of $37.43M for 2025 and has missed earnings expectations for the last three quarters. Recent news highlights progress with LYMPHIR, including Phase 1 data presentations at ASCO and international expansion, alongside $5.6M in net revenue for the first half of 2026.
Despite a high analyst buy consensus (83%), CTXR faces significant fundamental challenges with negative profitability and cash burn. Investment opportunity hinges on successful commercialization of LYMPHIR, but risks include ongoing losses, dilution from recent financing, and clinical execution uncertainties. The stock remains speculative with high risk-reward dynamics.
ESPO, the VanEck Video Gaming and eSports ETF, trades at $91.78, down 0.62% on the day. Technical indicators show a bullish trend with moving averages signaling strength, though oscillators are neutral and short-term RSI levels suggest overbought conditions. Recent news highlights institutional accumulation and AI-driven profit potential in the gaming sector, with Assetmark Inc. increasing its stake by 35.9% as of its latest 13F filing (SEC, Q1 2026).
The outlook for ESPO is supported by structural growth in digital entertainment and AI efficiency gains, but risks include sector volatility and high valuation multiples. The ETF offers exposure to a high-growth industry, yet investors face concentration risk in gaming stocks and sensitivity to consumer discretionary spending trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About VanEck Video Gaming and eSports ETF
ESPO is a thematic ETF that invests in the global video gaming and eSports industry. It provides exposure to companies involved in game development, hardware, and streaming, including major firms like Tencent, Nintendo, and Electronic Arts.
Read more on ESPO →
